177 related articles for article (PubMed ID: 28893469)
21. Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent.
Bhatt J; Mukherjee A; Shinto A; Koramadai Karuppusamy K; Korde A; Kumar M; Sarma HD; Repaka K; Dash A
Nucl Med Biol; 2018; 62-63():47-53. PubMed ID: 29883883
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Radiolabeling, and Preliminary in vivo Evaluation of [
Farn SS; Chang KW; Lin WC; Yu HM; Lin KL; Tseng YC; Chang Y; Yu CS; Lin WJ
Drug Des Devel Ther; 2021; 15():2577-2591. PubMed ID: 34168430
[TBL] [Abstract][Full Text] [Related]
23. Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography.
Iommelli F; De Rosa V; Gargiulo S; Panico M; Monti M; Greco A; Gramanzini M; Ortosecco G; Fonti R; Brunetti A; Del Vecchio S
Clin Cancer Res; 2014 Sep; 20(18):4806-15. PubMed ID: 25052479
[TBL] [Abstract][Full Text] [Related]
24. Peptide synthesis, characterization and ⁶⁸Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT.
Ebenhan T; Chadwick N; Sathekge MM; Govender P; Govender T; Kruger HG; Marjanovic-Painter B; Zeevaart JR
Nucl Med Biol; 2014; 41(5):390-400. PubMed ID: 24630816
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
[TBL] [Abstract][Full Text] [Related]
26. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
Eder M; Krivoshein AV; Backer M; Backer JM; Haberkorn U; Eisenhut M
Nucl Med Biol; 2010 May; 37(4):405-12. PubMed ID: 20447550
[TBL] [Abstract][Full Text] [Related]
27. Clinical Translation of [
Xavier C; Blykers A; Laoui D; Bolli E; Vaneyken I; Bridoux J; Baudhuin H; Raes G; Everaert H; Movahedi K; Van Ginderachter JA; Devoogdt N; Caveliers V; Lahoutte T; Keyaerts M
Mol Imaging Biol; 2019 Oct; 21(5):898-906. PubMed ID: 30671739
[TBL] [Abstract][Full Text] [Related]
28. Rational approach to the synthesis, evaluation, and (68)ga labeling of a novel 4-anilinoquinoline epidermal growth factor receptor inhibitor as a new imaging agent that selectively targets the epidermal growth factor receptor tyrosine kinase.
Theeraladanon C; Takahashi N; Shiina M; Hamada K; Takada Y; Endo H; Tateishi U; Oka T; Ogata K; Inoue T
Cancer Biother Radiopharm; 2010 Aug; 25(4):479-85. PubMed ID: 20735208
[TBL] [Abstract][Full Text] [Related]
29. 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
Zannetti A; Iommelli F; Speranza A; Salvatore M; Del Vecchio S
J Nucl Med; 2012 Mar; 53(3):443-50. PubMed ID: 22331221
[TBL] [Abstract][Full Text] [Related]
30. Development of a Fluorinated Analogue of Erlotinib for PET Imaging of EGFR Mutation-Positive NSCLC.
Shamni O; Grievink H; Itamar B; Mishani E; Abourbeh G
Mol Imaging Biol; 2019 Aug; 21(4):696-704. PubMed ID: 30377939
[TBL] [Abstract][Full Text] [Related]
31. In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.
Kang CM; Kim SM; Koo HJ; Yim MS; Lee KH; Ryu EK; Choe YS
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):198-206. PubMed ID: 23096079
[TBL] [Abstract][Full Text] [Related]
32. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
[TBL] [Abstract][Full Text] [Related]
33. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).
Fournier P; Dumulon-Perreault V; Ait-Mohand S; Tremblay S; Bénard F; Lecomte R; Guérin B
Bioconjug Chem; 2012 Aug; 23(8):1687-93. PubMed ID: 22770480
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging.
Varasteh Z; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Sandström M; Selvaraju RK; Malmberg J; Tolmachev V; Orlova A
Bioconjug Chem; 2013 Jul; 24(7):1144-53. PubMed ID: 23763444
[TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody.
Engle JW; Hong H; Zhang Y; Valdovinos HF; Myklejord DV; Barnhart TE; Theuer CP; Nickles RJ; Cai W
Mol Pharm; 2012 May; 9(5):1441-8. PubMed ID: 22519890
[TBL] [Abstract][Full Text] [Related]
36. Metabolically Stabilized (68)Ga-NOTA-Bombesin for PET Imaging of Prostate Cancer and Influence of Protease Inhibitor Phosphoramidon.
Richter S; Wuest M; Bergman CN; Krieger S; Rogers BE; Wuest F
Mol Pharm; 2016 Apr; 13(4):1347-57. PubMed ID: 26973098
[TBL] [Abstract][Full Text] [Related]
37. Preparation of radiolabeled erlotinib analogues and analysis of the effect of linkers.
Jain A; Kumar A; Vasumathy R; Subramanian S; Sarma HD; Satpati D
Bioorg Med Chem Lett; 2022 Nov; 76():128995. PubMed ID: 36152732
[TBL] [Abstract][Full Text] [Related]
38. Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency.
Singh AN; Liu W; Hao G; Kumar A; Gupta A; Öz OK; Hsieh JT; Sun X
Bioconjug Chem; 2011 Aug; 22(8):1650-62. PubMed ID: 21740059
[TBL] [Abstract][Full Text] [Related]
39. A Gallium-67/68-Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake.
Uehara T; Yokoyama M; Suzuki H; Hanaoka H; Arano Y
Clin Cancer Res; 2018 Jul; 24(14):3309-3316. PubMed ID: 29666303
[No Abstract] [Full Text] [Related]
40. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.
Luo H; England CG; Graves SA; Sun H; Liu G; Nickles RJ; Cai W
J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
